InsidersTradesSigma
Follow the 小林製薬株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on JP JP, under the authority of EDINET (Japan FSA). Market capitalisation: €402.2bn. The latest transaction was reported on 26 December 2025 (Holding update). Among the most active insiders: Oasis Management Company Ltd.. All data is free.
Analysts rate 小林製薬株式会社 Hold (neutral), based on 8 analysts. Average price target: JP¥5,496.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Kobayashi Pharmaceutical Co., Ltd. is a Japanese company that specializes in the manufacturing of pharmaceutical and healthcare products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.